A61K 31/7032
Attached to a polyol, i.e. compounds having two or more free or
Official title: attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
A61K31/7032 (Attached to a polyol, i.e. compounds having two or more free or) appears on 269 US grants and 535 published applications in this corpus.
Search patents in A61K- Granted patents
- 269
- Published applications
- 535
- Assignees
- 313
- Inventors
- 1,011
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 1 | 0 |
| 2002 | 6 | 14 |
| 2003 | 7 | 4 |
| 2004 | 5 | 9 |
| 2005 | 5 | 8 |
| 2006 | 1 | 5 |
| 2007 | 0 | 9 |
| 2008 | 4 | 17 |
| 2009 | 2 | 9 |
| 2010 | 4 | 18 |
| 2011 | 5 | 19 |
| 2012 | 0 | 31 |
| 2013 | 9 | 20 |
| 2014 | 16 | 29 |
| 2015 | 17 | 37 |
| 2016 | 17 | 35 |
| 2017 | 21 | 27 |
| 2018 | 20 | 29 |
| 2019 | 13 | 20 |
| 2020 | 23 | 28 |
| 2021 | 15 | 38 |
| 2022 | 16 | 31 |
| 2023 | 13 | 28 |
| 2024 | 10 | 22 |
| 2025 | 18 | 30 |
| 2026 | 5 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for treating neurodegenerative diseases22 Sep 2026US 12,740,995 B2Augusta University Research Institute, Inc.
- Liposomal formulations, and methods of using and preparing thereof28 Jul 2026US 12,691,131 B2Glycomine, Inc.
- Dermatological collar for non-human animals28 Apr 2026US 12,611,374 B2Bioiberica, S.A.U.
- CD1d-ligand-compound-containing liposome preparation having improved pharmacokinetics14 Apr 2026US 12,599,559 B2Osaka University
- IP and IP analogs dosage regimens for the treatment of ectopic calcifications7 Apr 2026US 12,594,290 B2Sanifit Therapeutics S.A.
- Compositions and methodology for delivery of alpha-galactosylceramide compounds1 Oct 2026US 2026/0294822 A1EnGeneIC Molecular Delivery Pty Ltd
- Methods for treating corneal injuries1 Oct 2026US 2026/0294849 A1National Taiwan University
- Uses of Compositions Comprising a Prebiotic Component10 Sep 2026US 2026/0263505 A1Mead Johnson Nutrition Company
- Composition for treating atopic dermatitis10 Sep 2026US 2026/0263511 A1Hyphens Pharma Pte. Ltd.
- Cd1d-ligand-compound-containing liposome preparation having improved pharmacokinetics30 Jul 2026US 2026/0216069 A1Osaka University
Most cited
By later US patents
- Acidic insulin preparations having improved stability68US 7,476,652 B2Sanofi-Aventis Deutschland GmbH · 2009
- Use of inhibitors of bruton's tyrosine kinase (Btk)52US 8,754,090 B2Pharmacyclics, Inc. · 2014
- NKT cell activators containing α-glycosylceramides50US 6,531,453 B1Kirin Beera Kabushiki Kaisha · 2003
- Acidic insulin preparations having improved stability50US 7,713,930 B2Sanofi-Aventis Deutschland GmbH · 2010
- Use of inhibitors of Bruton's tyrosine kinase (Btk)50US 8,999,999 B2Pharmacyclics, Inc. · 2015